Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Invivyd Inc (IVVD)

Invivyd Inc (IVVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Invivyd Inc 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 USA

https://invivyd.com Employees: 100 P: 781-819-0080

Sector:

Medical

Description:

INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 519,864
Enterprise Value, $K 450,514
Shares Outstanding, K 233,123
Annual Sales, $ 25,380 K
Annual Net Income, $ -169,930 K
Last Quarter Sales, $ 13,130 K
Last Quarter Net Income, $ -10,470 K
EBIT, $ -62,230 K
EBITDA, $ -59,120 K
60-Month Beta 0.61
% of Insider Shareholders 25.40%
% of Institutional Shareholders 70.36%
Float, K 173,910
% Float 74.60%
Short Volume Ratio 0.33

Growth:

1-Year Return 290.68%
3-Year Return 12.63%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/06/25
Next Earnings Date N/A
Earnings Per Share ttm -0.47
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 88.24%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IVVD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -92.97%
Return-on-Assets % -51.88%
Profit Margin % -669.54%
Debt/Equity 0.00
Price/Sales 20.39
Price/Cash Flow N/A
Price/Book 5.56
Book Value/Share 0.40
Interest Coverage -1.68
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar